K201 (JTV519) Suppresses Spontaneous Ca2+ Release and [3H]ryanodine Binding to RyR2 Irrespective of FKBP12.6 Association

Overview

Journal Biochem J

Specialty Biochemistry

Date 2007 Feb 23

PMID 17313373

Citations 42

Authors

Donald J Hunt

Peter P Jones

Ruiwu Wang

Wenqian Chen

Jeff Bolstad

Keyun Chen

Yakhin Shimoni

S R Wayne Chen

Affiliations

Soon will be listed here.

Abstract

K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial. It is believed to stabilize the closed state of the RyR2 (cardiac ryanodine receptor) by increasing its affinity for the FKBP12.6 (12.6 kDa FK506 binding protein) [Wehrens, Lehnart, Reiken, Deng, Vest, Cervantes, Coromilas, Landry and Marks (2004) Science 304, 292-296]. In the present study, we investigated the effect of K201 on spontaneous Ca2+ release induced by Ca2+ overload in rat ventricular myocytes and in HEK-293 cells (human embryonic kidney cells) expressing RyR2 and the role of FKBP12.6 in the action of K201. We found that K201 abolished spontaneous Ca2+ release in cardiac myocytes in a concentration-dependent manner. Treating ventricular myocytes with FK506 to dissociate FKBP12.6 from RyR2 did not affect the suppression of spontaneous Ca2+ release by K201. Similarly, K201 was able to suppress spontaneous Ca2+ release in FK506-treated HEK-293 cells co-expressing RyR2 and FKBP12.6. Furthermore, K201 suppressed spontaneous Ca2+ release in HEK-293 cells expressing RyR2 alone and in cells co-expressing RyR2 and FKBP12.6 with the same potency. In addition, K201 inhibited [3H]ryanodine binding to RyR2-wt (wild-type) and an RyR2 mutant linked to ventricular tachycardia and sudden death, N4104K, in the absence of FKBP12.6. These observations demonstrate that FKBP12.6 is not involved in the inhibitory action of K201 on spontaneous Ca2+ release. Our results also suggest that suppression of spontaneous Ca2+ release and the activity of RyR2 contributes, at least in part, to the anti-arrhythmic properties of K201.

Citing Articles

Dual effect of cardiac FKBP12.6 overexpression on excitation-contraction coupling and the incidence of ventricular arrhythmia depending on its expression level.

Gandon-Renard M, Val-Blasco A, Oughlis C, Gerbaud P, Lefebvre F, Gomez S J Mol Cell Cardiol. 2024; 188:15-29.

PMID: 38224852 PMC: 11153830. DOI: 10.1016/j.yjmcc.2024.01.003.

Clustering properties of the cardiac ryanodine receptor in health and heart failure.

Waddell H, Mereacre V, Alvarado F, Munro M J Mol Cell Cardiol. 2023; 185:38-49.

PMID: 37890552 PMC: 10717225. DOI: 10.1016/j.yjmcc.2023.10.012.

ASIC1a is required for neuronal activation via low-intensity ultrasound stimulation in mouse brain.

Lim J, Tai H, Liao W, Chu Y, Hao C, Huang Y Elife. 2021; 10.

PMID: 34569932 PMC: 8510583. DOI: 10.7554/eLife.61660.

Butyrate Feeding Reverses CypD-Related Mitoflash Phenotypes in Mouse Myofibers.

Li A, Li X, Yi J, Ma J, Zhou J Int J Mol Sci. 2021; 22(14).

PMID: 34299032 PMC: 8304904. DOI: 10.3390/ijms22147412.

Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.

Al Kury L J Diabetes Res. 2020; 2020:1942086.

PMID: 33274235 PMC: 7683117. DOI: 10.1155/2020/1942086.

References

Kass R, Tsien R . Fluctuations in membrane current driven by intracellular calcium in cardiac Purkinje fibers. Biophys J. 1982; 38(3):259-69. PMC: 1328867. DOI: 10.1016/S0006-3495(82)84557-8. View

Lakatta E . Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res. 1992; 26(3):193-214. DOI: 10.1093/cvr/26.3.193. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Inagaki K, Kihara Y, Izumi T, Sasayama S . The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts. Cardiovasc Drugs Ther. 2000; 14(5):489-95. DOI: 10.1023/a:1007884905461. View

Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S . Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006; 99(3):292-8. DOI: 10.1161/01.RES.0000235869.50747.e1. View

Orchard C, Eisner D, Allen D . Oscillations of intracellular Ca2+ in mammalian cardiac muscle. Nature. 1983; 304(5928):735-8. DOI: 10.1038/304735a0. View

Towbin H, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9):4350-4. PMC: 411572. DOI: 10.1073/pnas.76.9.4350. View

Wehrens X, Lehnart S, Reiken S, Deng S, Vest J, Cervantes D . Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science. 2004; 304(5668):292-6. DOI: 10.1126/science.1094301. View

Stange M, Xu L, Balshaw D, Yamaguchi N, Meissner G . Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem. 2003; 278(51):51693-702. DOI: 10.1074/jbc.M310406200. View

10.

Jiang D, Wang R, Xiao B, Kong H, Hunt D, Choi P . Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res. 2005; 97(11):1173-81. DOI: 10.1161/01.RES.0000192146.85173.4b. View

11.

Hachida M, Kihara S, Nonoyama M, Koyanagi H . Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation. J Card Surg. 2000; 14(3):187-93. DOI: 10.1111/j.1540-8191.1999.tb00977.x. View

12.

Shimoni Y, Chuang M, Abel E, Severson D . Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J Physiol. 2003; 555(Pt 2):345-54. PMC: 1664833. DOI: 10.1113/jphysiol.2003.055590. View

13.

Jiang M, Lokuta A, Farrell E, Wolff M, Haworth R, Valdivia H . Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res. 2002; 91(11):1015-22. DOI: 10.1161/01.res.0000043663.08689.05. View

14.

Kumagai K, Nakashima H, Gondo N, Saku K . Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J Cardiovasc Electrophysiol. 2003; 14(8):880-4. DOI: 10.1046/j.1540-8167.2003.03050.x. View

15.

Kannankeril P, Mitchell B, Goonasekera S, Chelu M, Zhang W, Sood S . Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci U S A. 2006; 103(32):12179-84. PMC: 1567715. DOI: 10.1073/pnas.0600268103. View

16.

Pogwizd S, Bers D . Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med. 2004; 14(2):61-6. DOI: 10.1016/j.tcm.2003.12.002. View

17.

Wier W, Kort A, Stern M, Lakatta E, Marban E . Cellular calcium fluctuations in mammalian heart: direct evidence from noise analysis of aequorin signals in Purkinje fibers. Proc Natl Acad Sci U S A. 1983; 80(23):7367-71. PMC: 390056. DOI: 10.1073/pnas.80.23.7367. View

18.

Janse M . Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res. 2004; 61(2):208-17. DOI: 10.1016/j.cardiores.2003.11.018. View

19.

Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S . FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation. 2003; 107(3):477-84. DOI: 10.1161/01.cir.0000044917.74408.be. View

20.

Boyden P, Dun W, Barbhaiya C, Ter Keurs H . 2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart. Heart Rhythm. 2005; 1(2):218-26. PMC: 4289136. DOI: 10.1016/j.hrthm.2004.03.068. View